88 related articles for article (PubMed ID: 1797157)
1. Mechanism and clinical relevance of elevated levels of circulating asialoglycoproteins.
Sawamura T; Shiozaki Y
Targeted Diagn Ther; 1991; 4():215-34. PubMed ID: 1797157
[No Abstract] [Full Text] [Related]
2. Decrease of a hepatic binding protein specific for asialoglycoproteins with accumulation of serum asialoglycoproteins in galactosamine-treated rats.
Sawamura T; Kawasato S; Shiozaki Y; Sameshima Y; Nakada H; Tashiro Y
Gastroenterology; 1981 Sep; 81(3):527-33. PubMed ID: 7250640
[TBL] [Abstract][Full Text] [Related]
3. ["Galactosamine refractory" regenerating liver--a model for studies on the etiology mechanism of galactosamine hepatitis].
Reutter W; Bauer C; Bachmann W; Lesch R
Hoppe Seylers Z Physiol Chem; 1972 May; 353(5):747. PubMed ID: 5069316
[No Abstract] [Full Text] [Related]
4. [Functional diagnosis of liver diseases].
Schmidt FW
Internist (Berl); 1967 Dec; 8(12):431-8. PubMed ID: 4873386
[No Abstract] [Full Text] [Related]
5. Clinical application of the measurement of serum asialoglycoproteins to estimate residual liver function in patients with chronic liver diseases with or without hepatocellular carcinoma.
Sawamura T; Kawasato S; Tsuda M; Naitoh Y; Shiozaki Y; Sameshima Y
Gastroenterol Jpn; 1985 Jun; 20(3):201-8. PubMed ID: 2995187
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein abnormalities in galactosamine hepatitis: a model of experimental lecithin:cholesterol acyltransferase deficiency.
Sabesin SM; Kuiken LB; Ragland JB
Scand J Clin Lab Invest Suppl; 1978; 150():187-93. PubMed ID: 746347
[No Abstract] [Full Text] [Related]
7. [Preliminary observations on D-galactosamine-induced hepatic failure in rat models (author's transl)].
Niu Z
Zhonghua Yi Xue Za Zhi; 1981 Jun; 61(6):350-3. PubMed ID: 6796235
[No Abstract] [Full Text] [Related]
8. [Changes in the bilirubin fractions in the acute and chronic hepatitis and liver cirrhosis (Eberlaine's technique)].
Sokolova GM
Klin Med (Mosk); 1970 Jan; 48(1):96-102. PubMed ID: 5419575
[No Abstract] [Full Text] [Related]
9. Patterns of ligand binding to normal, regenerating, preneoplastic, and neoplastic rat hepatocytes.
Harris L; Preat V; Farber E
Cancer Res; 1987 Aug; 47(15):3954-8. PubMed ID: 3038301
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic value of serum bile acids in chronic diseases of the liver].
Testa R; Bocchini R; Dellepiane F; Dodero M; Celle G
Med Chir Dig; 1980; 9(2):95-7. PubMed ID: 7401731
[No Abstract] [Full Text] [Related]
11. Control of endotoxinemia in liver disease by lactulose and paromomycin.
Scevola D; Magliulo E; Trpin L; Benzi-Cipelli R; Bernardi R
Boll Ist Sieroter Milan; 1979 Jul; 58(3):242-7. PubMed ID: 518757
[TBL] [Abstract][Full Text] [Related]
12. Abnormal platelet function and ultrastructure in fulminant hepatic failure.
Rubin MH; Weston MJ; Bullock G; Roberts J; Langley PG; White YS; Williams R
Q J Med; 1977 Jul; 46(183):339-52. PubMed ID: 918251
[No Abstract] [Full Text] [Related]
13. [Liver function test after nicotinic acid loading. I. A clinical study].
Finck C; Jorke D
Acta Hepatosplenol; 1968; 15(5):315-21. PubMed ID: 5707324
[No Abstract] [Full Text] [Related]
14. [Diagnosis of mild cases of liver dysfunction].
Hisamitsu T; Hayashi N; Ajiki K; Tamiya M; Nara S
Nihon Rinsho; 1974 Dec; 32(12):3549-55. PubMed ID: 4477205
[No Abstract] [Full Text] [Related]
15. [Clinical and experimental studies of hepatic disproteinemia].
Pons Romero F; Pérez Miranda M
Rev Med Univ Navarra; 1972 Jun; 16(2):137-51. PubMed ID: 4643588
[No Abstract] [Full Text] [Related]
16. Blood ammonia in portal hypertension and liver diseases in children.
Michalowicz-Wojczyńska E
Pol Med J; 1969; 8(5):1101-10. PubMed ID: 5310033
[No Abstract] [Full Text] [Related]
17. Development of a rapid, immunochromatographic strip test for serum asialo alpha1-acid glycoprotein in patients with hepatic disease.
Lee EY; Kang JH; Kim KA; Chung TW; Kim HJ; Yoon DY; Lee HG; Kwon DH; Kim JW; Kim CH; Song EY
J Immunol Methods; 2006 Jan; 308(1-2):116-23. PubMed ID: 16403512
[TBL] [Abstract][Full Text] [Related]
18. Experimental galactosamine-induced hepatitis. Effect of anticoagulant and antifibrinolytic agents on microclot formation.
Müller-Berghaus G; Reuter C; Bleyl U
Am J Pathol; 1976 Feb; 82(2):393-406. PubMed ID: 1251892
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity of serum glutamic oxaloacetic transaminase and bile acid levels for the detection of experimental liver injury in rats.
Mihas AA; Gibson RG; Mihas TA; Hirschowitz BI
J Med; 1981; 12(4):237-42. PubMed ID: 6947035
[TBL] [Abstract][Full Text] [Related]
20. Clinical utility of breath tests for the assessment of hepatic function.
Baker AL; Kotake AN; Schoeller DA
Semin Liver Dis; 1983 Nov; 3(4):318-29. PubMed ID: 6359427
[No Abstract] [Full Text] [Related]
[Next] [New Search]
